Last reviewed · How we verify

NCT06013644

Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome

Status unknown EARLY_PHASE1 Last updated 28 August 2023
What this trial tests

EARLY_PHASE1 trial testing Acupuncture needle in Myofascial Trigger Point Pain in 39 participants. Status unknown.

Timeline
3 June 2023
Primary endpoint
1 February 2024
1 February 2024

Quick facts

Lead sponsorCairo University
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment39
Start date3 June 2023
Primary completion1 February 2024
Estimated completion1 February 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 15 to 60, any sex, with Myofascial Trigger Point Pain or Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluating myofascial pain dysfunction symptoms using acupuncture, dry needle and Botox injection using electromyography and visual Analogue Scale on two time intervals at 2 and 6 months after the intervention

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acupuncture needle

Trials testing the same drug.

Other recruiting trials for Myofascial Trigger Point Pain

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06013644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing